Peripheral levels of IL-6 were not elevated in this cohort of breast cancer patients compared to healthy donors, and no correlation was found between impaired IL-6 signaling response in naïve CD4+ T cells and plasma IL-6 levels. This evidence concerns the gene CD4 and breast carcinoma.